(+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of BCL2A1 mRNA CTD PMID:17971868 (-)-demecolcine increases expression ISO RGD:733985 6480464 Demecolcine results in increased expression of BCL2A1 mRNA CTD PMID:23649840 (S)-naringenin increases expression ISO RGD:733985 6480464 naringenin metabolite results in increased expression of BCL2A1 mRNA CTD PMID:36235125 (S)-naringenin multiple interactions ISO RGD:733985 6480464 [naringenin co-treated with bisphenol A] results in increased expression of BCL2A1 mRNA, [naringenin metabolite co-treated with bisphenol A] results in increased expression of BCL2A1 mRNA CTD PMID:36235125 (S)-nicotine decreases expression ISO RGD:733985 6480464 Nicotine results in decreased expression of BCL2A1 mRNA CTD PMID:18247414 1'-acetoxychavicol acetate multiple interactions ISO RGD:733985 6480464 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] CTD PMID:15905586 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o, p'-DDT results in increased expression of BCL2A1 mRNA CTD PMID:22937105 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP 6480464 o, p'-DDT analog results in decreased expression of BCL2A1 mRNA CTD PMID:22937105 1,2-dimethylhydrazine increases expression ISO RGD:1621639 6480464 1, 2-Dimethylhydrazine results in increased expression of BCL2A1B mRNA CTD PMID:22206623 1-nitropyrene increases expression ISO RGD:733985 6480464 1-nitropyrene results in increased expression of BCL2A1 mRNA CTD PMID:21540303 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2A1 mRNA CTD PMID:19520675 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BCL2A1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1621639 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2A1B mRNA CTD PMID:21041162 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1621639 6480464 Trinitrobenzenesulfonic Acid results in increased expression of BCL2A1B mRNA CTD PMID:17982090 2-hydroxypropanoic acid decreases expression ISO RGD:733985 6480464 Lactic Acid results in decreased expression of BCL2A1 mRNA CTD PMID:30851411 2-naphthylamine increases expression ISO RGD:733985 6480464 2-Naphthylamine results in increased expression of BCL2A1 mRNA CTD PMID:18247414 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:733985 6480464 Triiodothyronine promotes the reaction [tamibarotene results in increased expression of BCL2A1A mRNA] CTD PMID:11201846 4-hydroxynon-2-enal decreases expression ISO RGD:1621639 6480464 4-hydroxy-2-nonenal results in decreased expression of BCL2A1B mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide multiple interactions ISO RGD:733985 6480464 Fenretinide inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] CTD PMID:16230421 4-hydroxyphenyl retinamide decreases expression ISO RGD:733985 6480464 Fenretinide results in decreased expression of BCL2A1 protein CTD PMID:16230421 4-hydroxyphenyl retinamide increases expression ISO RGD:1621639 6480464 Fenretinide results in increased expression of BCL2A1 mRNA CTD PMID:28973697 4-nitroquinoline N-oxide increases expression ISO RGD:1621639 6480464 4-Nitroquinoline-1-oxide results in increased expression of BCL2A1B mRNA CTD PMID:22561872 6alpha-methylprednisolone decreases expression ISO RGD:733985 6480464 Methylprednisolone results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 acetamide increases expression EXP 6480464 acetamide results in increased expression of BCL2A1 mRNA CTD PMID:31881176 actinomycin D multiple interactions ISO RGD:733985 6480464 BCL2A1 protein inhibits the reaction [Dactinomycin results in increased susceptibility to TNF protein] CTD PMID:11880364 aflatoxin B1 increases expression ISO RGD:733985 6480464 Aflatoxin B1 results in increased expression of BCL2A1 mRNA CTD PMID:21641981 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of BCL2A1 mRNA CTD PMID:25378103 aflatoxin B1 increases methylation ISO RGD:733985 6480464 Aflatoxin B1 results in increased methylation of BCL2A1 gene CTD PMID:27153756 all-trans-retinoic acid multiple interactions ISO RGD:733985 6480464 [Tretinoin co-treated with Arsenic Trioxide co-treated with Butyrates] results in increased expression of BCL2A1 mRNA more ... CTD PMID:11133770 more ... all-trans-retinoic acid increases expression ISO RGD:733985 6480464 Tretinoin results in increased expression of BCL2A1 mRNA, Tretinoin results in increased expression of BCL2A1A protein CTD PMID:10673743 more ... antirheumatic drug decreases expression ISO RGD:733985 6480464 Antirheumatic Agents results in decreased expression of BCL2A1 mRNA CTD PMID:17696278 , PMID:24449571 antirheumatic drug multiple interactions ISO RGD:733985 6480464 BCL2A1 mRNA results in decreased susceptibility to [Methotrexate co-treated with Antirheumatic Agents] CTD PMID:22753658 aristolochic acid A increases expression ISO RGD:733985 6480464 aristolochic acid I results in increased expression of BCL2A1 mRNA CTD PMID:33212167 arsenite(3-) decreases expression ISO RGD:1621639 6480464 arsenite results in decreased expression of BCL2A1B mRNA CTD PMID:18191166 arsenous acid decreases expression ISO RGD:733985 6480464 Arsenic Trioxide results in decreased expression of BCL2A1 mRNA CTD PMID:19128835 arsenous acid increases expression ISO RGD:733985 6480464 Arsenic Trioxide results in increased expression of BCL2A1 mRNA CTD PMID:10673743 , PMID:17530438 arsenous acid multiple interactions ISO RGD:733985 6480464 [Tretinoin co-treated with Arsenic Trioxide co-treated with Butyrates] results in increased expression of BCL2A1 mRNA more ... CTD PMID:11133770 more ... azathioprine decreases expression ISO RGD:733985 6480464 Azathioprine results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 bathocuproine disulfonic acid multiple interactions ISO RGD:733985 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BCL2A1 mRNA], bathocuproine sulfonate inhibits the reaction [pyrrolidine dithiocarbamic acid inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BCL2A1 mRNA]] CTD PMID:15477007 benzene increases expression ISO RGD:733985 6480464 Benzene results in increased expression of BCL2A1 mRNA CTD PMID:20359517 benzo[a]pyrene decreases expression ISO RGD:733985 6480464 Benzo(a)pyrene results in decreased expression of BCL2A1 mRNA CTD PMID:18247414 benzo[a]pyrene increases methylation ISO RGD:733985 6480464 Benzo(a)pyrene results in increased methylation of BCL2A1 promoter CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:733985 6480464 Benzo(a)pyrene affects the methylation of BCL2A1 exon CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1621639 6480464 Benzo(a)pyrene results in decreased expression of BCL2A1B mRNA CTD PMID:21569818 benzo[a]pyrene increases expression ISO RGD:733985 6480464 Benzo(a)pyrene results in increased expression of BCL2A1 mRNA CTD PMID:20106945 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BCL2A1 mRNA CTD PMID:18180321 bisphenol A multiple interactions ISO RGD:733985 6480464 [naringenin co-treated with bisphenol A] results in increased expression of BCL2A1 mRNA, [naringenin metabolite co-treated with bisphenol A] results in increased expression of BCL2A1 mRNA CTD PMID:36235125 bisphenol A decreases expression ISO RGD:1621639 6480464 bisphenol A results in decreased expression of BCL2A1B mRNA CTD PMID:25594700 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of BCL2A1 mRNA CTD PMID:25181051 bortezomib increases expression ISO RGD:733985 6480464 Bortezomib results in increased expression of BCL2A1A protein CTD PMID:20051518 bortezomib multiple interactions ISO RGD:733985 6480464 [romidepsin co-treated with Bortezomib] results in decreased expression of BCL2A1 protein CTD PMID:18223231 butanal increases expression ISO RGD:733985 6480464 butyraldehyde results in increased expression of BCL2A1 mRNA CTD PMID:26079696 cadmium dichloride decreases expression ISO RGD:733985 6480464 Cadmium Chloride results in decreased expression of BCL2A1 mRNA, Cadmium Chloride results in decreased expression of BCL2A1 protein CTD PMID:12160620 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of BCL2A1 mRNA CTD PMID:25993096 calcitriol increases expression ISO RGD:733985 6480464 Calcitriol results in increased expression of BCL2A1 mRNA CTD PMID:15951637 , PMID:16847355 cannabidiol multiple interactions ISO RGD:733985 6480464 [Cannabidiol co-treated with moringin] results in increased expression of BCL2A1 mRNA CTD PMID:30096889 carbon monoxide multiple interactions ISO RGD:733985 6480464 BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]], MAPK14 protein affects the reaction [BCL2A1 protein inhibits the reaction [NFKBIA protein inhibits the reaction [[HMOX1 protein results in increased chemical synthesis of Carbon Monoxide] which results in decreased susceptibility to TNF protein]]] CTD PMID:11880364 carbon nanotube increases expression ISO RGD:733985 6480464 Nanotubes, Carbon analog results in increased expression of BCL2A1 mRNA CTD PMID:25102311 CGP 52608 multiple interactions ISO RGD:733985 6480464 CGP 52608 promotes the reaction [RORA protein binds to BCL2A1 gene] CTD PMID:28238834 cholesterol increases expression EXP 6480464 Cholesterol analog results in increased expression of BCL2A1 mRNA CTD PMID:19477266 choline multiple interactions ISO RGD:1621639 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BCL2A1B mRNA CTD PMID:20938992 chromium(6+) affects expression ISO RGD:1621639 6480464 chromium hexavalent ion affects the expression of BCL2A1B mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression ISO RGD:1621639 6480464 Ciguatoxins affects the expression of BCL2A1B mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:733985 6480464 Cisplatin results in increased expression of BCL2A1 mRNA CTD PMID:19561079 more ... copper atom multiple interactions ISO RGD:733985 6480464 [Chelating Agents binds to Copper] which results in increased expression of BCL2A1 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO RGD:733985 6480464 [Chelating Agents binds to Copper] which results in increased expression of BCL2A1 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO RGD:733985 6480464 Copper Sulfate results in increased expression of BCL2A1 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:733985 6480464 Asbestos, Crocidolite results in increased expression of BCL2A1 mRNA CTD PMID:25351596 CU-O LINKAGE decreases expression ISO RGD:733985 6480464 cupric oxide results in decreased expression of BCL2A1 mRNA CTD PMID:22077320 curcumin multiple interactions ISO RGD:733985 6480464 Curcumin inhibits the reaction [TNF protein results in increased expression of BCL2A1 mRNA] CTD PMID:16219905 curcumin decreases expression ISO RGD:733985 6480464 Curcumin results in decreased expression of BCL2A1 mRNA CTD PMID:17596214 dexamethasone increases expression ISO RGD:1621639 6480464 Dexamethasone results in increased expression of BCL2A1B mRNA CTD PMID:21041162 diarsenic trioxide increases expression ISO RGD:733985 6480464 Arsenic Trioxide results in increased expression of BCL2A1 mRNA CTD PMID:10673743 , PMID:17530438 diarsenic trioxide multiple interactions ISO RGD:733985 6480464 [Tretinoin co-treated with Arsenic Trioxide co-treated with Butyrates] results in increased expression of BCL2A1 mRNA more ... CTD PMID:11133770 more ... diarsenic trioxide decreases expression ISO RGD:733985 6480464 Arsenic Trioxide results in decreased expression of BCL2A1 mRNA CTD PMID:19128835 dichloromethane increases expression ISO RGD:733985 6480464 Methylene Chloride results in increased expression of BCL2A1 mRNA CTD PMID:20359517 diclofenac decreases expression ISO RGD:733985 6480464 Diclofenac results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 diethyl maleate decreases expression EXP 6480464 diethyl maleate results in decreased expression of BCL2A1 mRNA CTD PMID:21161181 diosgenin multiple interactions ISO RGD:733985 6480464 Diosgenin inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] CTD PMID:16331273 diosgenin decreases expression ISO RGD:733985 6480464 Diosgenin results in decreased expression of BCL2A1 protein CTD PMID:16331273 dioxygen decreases expression ISO RGD:1621639 6480464 Oxygen deficiency results in decreased expression of BCL2A1B mRNA CTD PMID:24205000 doxorubicin multiple interactions ISO RGD:733985 6480464 [Tretinoin results in increased expression of BCL2A1 mRNA] which results in decreased susceptibility to Doxorubicin CTD PMID:16572199 doxorubicin decreases expression ISO RGD:733985 6480464 Doxorubicin results in decreased expression of BCL2A1 mRNA CTD PMID:29803840 doxorubicin affects response to substance ISO RGD:733985 6480464 BCL2A1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of BCL2A1 mRNA CTD PMID:29391264 eriodictyol multiple interactions ISO RGD:733985 6480464 eriodictyol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2A1 mRNA] CTD PMID:20438634 ethyl methanesulfonate decreases expression ISO RGD:733985 6480464 Ethyl Methanesulfonate results in decreased expression of BCL2A1 mRNA CTD PMID:23649840 ethylbenzene increases expression ISO RGD:733985 6480464 ethylbenzene results in increased expression of BCL2A1 mRNA CTD PMID:20359517 Evodiamine multiple interactions ISO RGD:733985 6480464 evodiamine inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] CTD PMID:15710601 fenofibrate decreases expression ISO RGD:733985 6480464 Fenofibrate results in decreased expression of BCL2A1 mRNA CTD PMID:20520642 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of BCL2A1 mRNA CTD PMID:18035473 folic acid multiple interactions ISO RGD:1621639 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BCL2A1B mRNA CTD PMID:20938992 furan increases expression EXP 6480464 furan results in increased expression of BCL2A1 mRNA CTD PMID:22079235 Fusarenone X increases expression ISO RGD:1621639 6480464 fusarenon-X results in increased expression of BCL2A1B mRNA CTD PMID:24983900 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of BCL2A1 mRNA CTD PMID:22061828 glycochenodeoxycholic acid increases expression EXP 6480464 Glycochenodeoxycholic Acid results in increased expression of BCL2A1 mRNA CTD PMID:15767249 glyphosate increases expression ISO RGD:733985 6480464 glyphosate results in increased expression of BCL2A1 mRNA CTD PMID:31874349 guggulsterone multiple interactions ISO RGD:733985 6480464 pregna-4 more ... CTD PMID:15322087 imidazopyrazole increases expression ISO RGD:733985 6480464 imidazopyrazole analog results in increased expression of BCL2A1 mRNA CTD PMID:30388846 indole-3-methanol multiple interactions ISO RGD:733985 6480464 indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] CTD PMID:15811958 indometacin decreases expression ISO RGD:733985 6480464 Indomethacin results in decreased expression of BCL2A1 mRNA, Indomethacin results in decreased expression of BCL2A1 protein CTD PMID:17054584 ionomycin multiple interactions ISO RGD:733985 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BCL2A1 mRNA] more ... CTD PMID:15477007 iron(2+) sulfate (anhydrous) increases expression ISO RGD:733985 6480464 ferrous sulfate results in increased expression of BCL2A1 mRNA CTD PMID:21540303 isoflurane decreases expression EXP 6480464 Isoflurane results in decreased expression of BCL2A1 mRNA CTD PMID:16978161 kaempferol multiple interactions ISO RGD:733985 6480464 kaempferol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2A1 mRNA] CTD PMID:20438634 kojic acid increases expression ISO RGD:733985 6480464 kojic acid results in increased expression of BCL2A1 mRNA CTD PMID:16595896 L-methionine multiple interactions ISO RGD:1621639 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of BCL2A1B mRNA CTD PMID:20938992 lipopolysaccharide increases expression ISO RGD:1621639 6480464 Lipopolysaccharides results in increased expression of BCL2A1B mRNA CTD PMID:25890327 lipopolysaccharide multiple interactions ISO RGD:733985 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of BCL2A1 mRNA CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:733985 6480464 Lipopolysaccharides results in increased expression of BCL2A1 mRNA CTD PMID:15860229 more ... lonafarnib multiple interactions ISO RGD:733985 6480464 lonafarnib inhibits the reaction [TNF protein results in increased expression of BCL2A1 protein] CTD PMID:15090542 LY294002 multiple interactions ISO RGD:1621639 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Butyrates results in increased expression of BCL2A1 mRNA] CTD PMID:16256798 maneb increases expression ISO RGD:733985 6480464 Maneb results in increased expression of BCL2A1 mRNA CTD PMID:18266926 maneb multiple interactions ISO RGD:733985 6480464 [Paraquat co-treated with Maneb] results in increased expression of BCL2A1 protein CTD PMID:18266926 melphalan increases expression ISO RGD:733985 6480464 Melphalan results in increased expression of BCL2A1 mRNA CTD PMID:22363485 methotrexate decreases expression ISO RGD:733985 6480464 Methotrexate results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 methotrexate increases expression ISO RGD:733985 6480464 Methotrexate results in increased expression of BCL2A1 mRNA CTD PMID:17696278 , PMID:25575725 methotrexate decreases response to substance ISO RGD:733985 6480464 BCL2A1 mRNA results in decreased susceptibility to Methotrexate CTD PMID:22753658 methotrexate multiple interactions ISO RGD:733985 6480464 BCL2A1 mRNA results in decreased susceptibility to [Methotrexate co-treated with Antirheumatic Agents] CTD PMID:22753658 methyl methanesulfonate decreases expression ISO RGD:733985 6480464 Methyl Methanesulfonate results in decreased expression of BCL2A1 mRNA CTD PMID:23649840 methylisothiazolinone increases expression ISO RGD:733985 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of BCL2A1 mRNA CTD PMID:31629900 methylseleninic acid increases expression ISO RGD:733985 6480464 methylselenic acid results in increased expression of BCL2A1 mRNA CTD PMID:11830524 Mitotane increases expression EXP 6480464 Mitotane results in increased expression of BCL2A1 mRNA CTD PMID:23485034 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of BCL2A1 mRNA CTD PMID:21515302 N-(6-acetamidohexyl)acetamide multiple interactions ISO RGD:733985 6480464 [Tretinoin co-treated with arsenic trioxide co-treated with hexamethylene bisacetamide] results in increased expression of BCL2A1 mRNA, [Tretinoin co-treated with hexamethylene bisacetamide] results in increased expression of BCL2A1 mRNA CTD PMID:12130515 naphthalenes increases expression EXP 6480464 Naphthalenes results in increased expression of BCL2A1 protein CTD PMID:17337753 nickel atom multiple interactions ISO RGD:733985 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of BCL2A1A mRNA] CTD PMID:14575637 nickel atom increases expression ISO RGD:733985 6480464 Nickel results in increased expression of BCL2A1 mRNA CTD PMID:24768652 , PMID:25583101 nickel atom affects expression ISO RGD:733985 6480464 Nickel affects the expression of BCL2A1A mRNA CTD PMID:14575637 nickel dichloride increases expression ISO RGD:733985 6480464 nickel chloride results in increased expression of BCL2A1 mRNA CTD PMID:17312168 nickel sulfate increases expression ISO RGD:733985 6480464 nickel sulfate results in increased expression of BCL2A1 mRNA CTD PMID:16780908 nicotine decreases expression ISO RGD:733985 6480464 Nicotine results in decreased expression of BCL2A1 mRNA CTD PMID:18247414 o-xylene increases expression ISO RGD:733985 6480464 2-xylene results in increased expression of BCL2A1 mRNA CTD PMID:20359517 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of BCL2A1 mRNA CTD PMID:19562491 oxycodone decreases expression EXP 6480464 Oxycodone results in decreased expression of BCL2A1 mRNA CTD PMID:23439660 paracetamol affects expression ISO RGD:1621639 6480464 Acetaminophen affects the expression of BCL2A1B mRNA CTD PMID:17562736 paraquat decreases expression ISO RGD:733985 6480464 Paraquat results in decreased expression of BCL2A1 mRNA CTD PMID:18836921 paraquat multiple interactions ISO RGD:733985 6480464 [Paraquat co-treated with Maneb] results in increased expression of BCL2A1 protein CTD PMID:18266926 paraquat increases expression ISO RGD:733985 6480464 Paraquat results in increased expression of BCL2A1 mRNA, Paraquat results in increased expression of BCL2A1 protein CTD PMID:18056701 , PMID:18266926 pentanal increases expression ISO RGD:733985 6480464 pentanal results in increased expression of BCL2A1 mRNA CTD PMID:26079696 peptidoglycan increases expression ISO RGD:733985 6480464 Peptidoglycan results in increased expression of BCL2A1 mRNA CTD PMID:15860229 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:733985 6480464 5 more ... CTD PMID:15477007 more ... phorbol 13-acetate 12-myristate increases expression ISO RGD:733985 6480464 Tetradecanoylphorbol Acetate results in increased expression of BCL2A1 mRNA CTD PMID:20438634 pirinixic acid increases expression ISO RGD:1621639 6480464 pirinixic acid results in increased expression of BCL2A1B mRNA CTD PMID:23811191 piroxicam decreases expression ISO RGD:733985 6480464 Piroxicam results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 poly(I:C) multiple interactions EXP 6480464 [Poly I-C co-treated with HU 211] results in increased expression of BCL2A1 mRNA CTD PMID:26923065 prednisolone decreases expression ISO RGD:733985 6480464 Prednisolone results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1621639 6480464 Pregnenolone Carbonitrile results in decreased expression of BCL2A1B mRNA CTD PMID:22698814 propanal increases expression ISO RGD:733985 6480464 propionaldehyde results in increased expression of BCL2A1 mRNA CTD PMID:26079696 protein kinase inhibitor multiple interactions ISO RGD:733985 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of BCL2A1 mRNA] CTD PMID:28003376 pyridaben increases expression ISO RGD:1621639 6480464 pyridaben results in increased expression of BCL2A1 mRNA CTD PMID:22563483 pyrrolidine dithiocarbamate multiple interactions ISO RGD:733985 6480464 [bathocuproine sulfonate co-treated with pyrrolidine dithiocarbamic acid] inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of BCL2A1 mRNA] more ... CTD PMID:15477007 quercetin multiple interactions ISO RGD:733985 6480464 Quercetin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2A1 mRNA] CTD PMID:20438634 rac-lactic acid decreases expression ISO RGD:733985 6480464 Lactic Acid results in decreased expression of BCL2A1 mRNA CTD PMID:30851411 reactive oxygen species multiple interactions ISO RGD:733985 6480464 [[[CD40LG protein co-treated with IL4 protein] results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased phosphorylation of and results in increased stability of TP53 protein] which results in increased expression of BCL2A1 protein CTD PMID:27634759 resveratrol decreases expression ISO RGD:733985 6480464 resveratrol results in decreased expression of BCL2A1 protein CTD PMID:17164350 resveratrol increases expression ISO RGD:733985 6480464 resveratrol results in increased expression of BCL2A1 mRNA CTD PMID:25888808 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of BCL2A1 mRNA CTD PMID:25905778 romidepsin multiple interactions ISO RGD:733985 6480464 [romidepsin co-treated with Bortezomib] results in decreased expression of BCL2A1 protein CTD PMID:18223231 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:733985 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of BCL2A1 mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:733985 6480464 [S-(1, 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of BCL2A1 mRNA CTD PMID:35811015 silicon dioxide increases expression ISO RGD:733985 6480464 Silicon Dioxide analog results in increased expression of BCL2A1 mRNA, Silicon Dioxide results in increased expression of BCL2A1 mRNA CTD PMID:21540303 more ... silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of BCL2A1 mRNA CTD PMID:22431001 simazine decreases expression ISO RGD:1621639 6480464 Simazine results in decreased expression of BCL2A1 mRNA CTD PMID:25461544 sodium arsenite increases expression ISO RGD:733985 6480464 sodium arsenite results in increased expression of BCL2A1 mRNA CTD PMID:12016162 , PMID:29049844 sodium aurothiomalate decreases expression ISO RGD:733985 6480464 Gold Sodium Thiomalate results in decreased expression of BCL2A1 mRNA CTD PMID:19192274 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of BCL2A1 mRNA CTD PMID:25993096 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of BCL2A1 mRNA CTD PMID:25905778 sulforaphane increases expression ISO RGD:733985 6480464 sulforaphane results in increased expression of BCL2A1 mRNA CTD PMID:26833863 tamibarotene multiple interactions ISO RGD:733985 6480464 Triiodothyronine promotes the reaction [tamibarotene results in increased expression of BCL2A1A mRNA] CTD PMID:11201846 tamibarotene increases expression ISO RGD:733985 6480464 tamibarotene results in increased expression of BCL2A1 mRNA, tamibarotene results in increased expression of BCL2A1A mRNA CTD PMID:11201846 , PMID:15498508 tetrachloromethane multiple interactions ISO RGD:1621639 6480464 PPARD protein affects the reaction [Carbon Tetrachloride results in increased expression of BCL2A1B mRNA] CTD PMID:18038451 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of BCL2A1 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1621639 6480464 titanium dioxide results in increased expression of BCL2A1B mRNA CTD PMID:23131501 more ... toluene increases expression ISO RGD:733985 6480464 Toluene results in increased expression of BCL2A1 mRNA CTD PMID:20359517 , PMID:28245982 topotecan increases expression EXP 6480464 Topotecan results in increased expression of BCL2A1 mRNA CTD PMID:25729387 Tributyltin oxide increases expression ISO RGD:733985 6480464 bis(tri-n-butyltin)oxide results in increased expression of BCL2A1 mRNA CTD PMID:24247028 trichloroethene increases expression ISO RGD:733985 6480464 Trichloroethylene results in increased expression of BCL2A1 mRNA CTD PMID:20359517 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of BCL2A1 mRNA CTD PMID:33387578 trichostatin A multiple interactions ISO RGD:733985 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of BCL2A1A mRNA] CTD PMID:14575637 triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of BCL2A1 mRNA CTD PMID:30589522 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of BCL2A1 mRNA CTD PMID:21515302 undecane increases expression EXP 6480464 undecane results in increased expression of BCL2A1 protein CTD PMID:17337753 vincristine increases expression ISO RGD:733985 6480464 Vincristine results in increased expression of BCL2A1 mRNA CTD PMID:23649840 vorinostat decreases expression ISO RGD:733985 6480464 vorinostat results in decreased expression of BCL2A1 protein CTD PMID:15897598 withaferin A multiple interactions ISO RGD:733985 6480464 withaferin A inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of BCL2A1 mRNA] CTD PMID:20438634 zerumbone decreases expression ISO RGD:733985 6480464 zerumbone results in decreased expression of BCL2A1 mRNA CTD PMID:16007145 zinc atom multiple interactions ISO RGD:733985 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of BCL2A1 mRNA CTD PMID:16979875 zinc dichloride increases expression ISO RGD:733985 6480464 zinc chloride results in increased expression of BCL2A1 mRNA CTD PMID:21540303 zinc(0) multiple interactions ISO RGD:733985 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of BCL2A1 mRNA CTD PMID:16979875 zoledronic acid decreases expression ISO RGD:733985 6480464 zoledronic acid results in decreased expression of BCL2A1 mRNA CTD PMID:19036117